Europe Cannabis Business Plan Sample

Spending on legal cannabis worldwide is expected to reach nearly $50 billion by 2027 at a compound annual growth rate (CAGR) of 13.7% from 2020 and hit $57 billion by 2030. The cannabis market in the United States and Canada is estimated to be about $46.5 billion while the remaining $10.5 billion would go to other markets. The recreational cannabis market will cover about 67% of the spending while medical cannabis will take up the remaining 33%.

While there are 41 million people in Canada and 342 million in the United States, the European Union is home to 450 million and has an estimated cannabis use prevalence of 8.4% among residents aged 15-64 (European Drug Report 2025) – representing a massive, untapped frontier. The most populous EU Member State is Germany (84 million, 18.7% of the EU total), followed by France (68 million, 15.1%), Italy (59 million, 13.1%), Spain (49 million, 10.9%) and Poland (36 million, 8%). The population of Great Britain is estimated at nearly 70 million people. The current population of Switzerland is 9 million people and Norway has another 5 million.

Reports prepared by the London-based advisory group Prohibition Partners valued European legal cannabis sales at €516 million in 2023, and by 2025, sales had nearly tripled to €1.5 billion, primarily driven by a 110% surge in medical cannabis sales in Germany and steady expansion in other major markets such as the UK and Czech Republic. Total legal cannabis sales in Europe are forecast to grow at a compound annual growth rate (CAGR) of 50% to reach €2.5 billion by 2027.

Cannabis business plan templates for other countries are available at cannabusinessplans.com.